A carregar...
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
BACKGROUND: We aimed to investigate the tau biomarker discrepancies of Alzheimer’s disease (AD) using plasma tau phosphorylated at threonine 181 (p-tau181), cerebrospinal fluid (CSF) p-tau181, and AV1451 positron emission tomography (PET). METHODS: In the Alzheimer’s Disease Neuroimaging Initiative,...
Na minha lista:
| Publicado no: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094494/ https://ncbi.nlm.nih.gov/pubmed/33947453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00834-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|